“flagship-ventures” Archives

in
Entry Author Date Location
Venture Veterans Frazier Commit New $262M Fund To Biopharma Bets 10/29/15 San Francisco
Taris 2.0: A Year After Buyout, VCs Bet $32M More on a Second Strike 10/27/15 Boston
TARIS Biomedical Receives $32,000,000 New Financing 10/27/15 Boston
Boston’s Life Science Disruptors 2015: The Photos 10/06/15 Boston
Five Takeaways From “Boston’s Life Science Disruptors” 10/02/15 Boston
Hear the Synlogic Story at Boston’s Life Science Disruptors Sept. 30 09/14/15 Boston
East Coast Biotech Roundup: Biogen, Watson, Data Dumps & More 09/11/15 Boston
Versant Walks Biotech “High Line” With a New Manhattan Incubator 08/24/15 New York
CRISPR Race Heats Up As Gates, Crossovers Put $120M Into Editas 08/10/15 Boston
“Boston’s Life Science Disruptors” to Share Their Stories on Sept. 30 07/23/15 Boston
East Coast Biotech Roundup: Flagship, SQZ, Epizyme, IPOs & More 06/26/15 Boston
Bon Appetit: Seres And Its Microbiome Gut Treatment Notch $134M IPO 06/25/15 Boston
On Eve of Seres IPO, A Rival Nonprofit Microbiome Treatment Expands 06/25/15 Boston
Flagship CEO on Backing NY Biotech, Moderna, and Investing in a Boom 06/22/15 New York
Lawrence, Gotsch, Tantoco & Others Talk Growing Startups in Cities 06/15/15 New York
Good Times Roll on for Biotech VCs As Clarus Bags New $500M Fund 06/09/15 Boston
Sharpening Its Focus On Drugs, Pronutria Bags $39M From Fidelity, Flagship 05/28/15 Boston
Gold Bugs? Seres Files For First IPO of Human Microbiome Era 05/27/15 Boston
Boston’s Innovation Future Hinges on People, Startups, Relationships 05/21/15 Boston
Eleven Bio’s Shares Routed as Dry Eye Drug Flunks Phase 3 Test 05/18/15 Boston
Denali Rises With $217M and Genentech Alumni to Fight Brain Diseases 05/14/15 San Francisco
Moderna’s Third mRNA Startup, Elpidera, Sets Sights on Rare Diseases 05/12/15 Boston
With $200M Raised, Joule Still Pushing Biofuels Production Facility 05/11/15 Boston
East Coast Biotech Roundup: NY Bio, Synageva, Kadmon & More 05/08/15 New York
Now Biotech-Only, Atlas Reloads With $280M Fund For New Startups 04/17/15 Boston
What’s Hot in Boston Biotech: The Photos 04/15/15 Boston
Pop That Bubble: 5 Reasons Biotech Needs A Different Metaphor 04/14/15 National
Blend Therapeutics Taps Former Clinical Data Chief Fromkin As New CEO 04/13/15 Boston
Seven Takeaways From “What’s Hot in Boston Biotech” 04/10/15 Boston
East Coast Biotech Roundup: NY Bio Fund, Sarepta, ZappRx, & More 04/03/15 Boston
Page 2 of 16 « previous page · next page »